<?xml version="1.0" ?>
<DOC>
   <DOCID>LA062694-0299</DOCID>
   <HEADLINE> BRIEFLY ; MEDICINE : HIV PATIENTS TO TEST CANCER MEDICATION</HEADLINE>
   <TEXT> UCLA ' s Center for AIDS Research and Education ( CARE ) is seeking HIV-positive subjects with Kaposi ' s sarcoma skin lesions to take_part in a clinical trial of a medication to treat Kaposi ' s sarcoma , the most common cancer found in people with AIDS . The usual treatment of Kaposi ' s sarcoma involves injections of various drugs into individual skin tumors . The medication being tested in the UCLA trial , LGD1057 , is a gel that patients can apply themselves . The four-week UCLA trial is for patients ages 18 and older . Patients may be allowed to continue treatment beyond four weeks if that is medically appropriate . For information , call : ( 310 ) 206-6414 .</TEXT>
</DOC>
